Revisiting the intrinsic mycobiome in pancreatic cancer
- PMID: 37532819
- PMCID: PMC11062486
- DOI: 10.1038/s41586-023-06292-1
Revisiting the intrinsic mycobiome in pancreatic cancer
Abstract
A growing body of literature suggests that alterations in the human microbiome are causative of disease initiation and progression. Aykut et al. present data supporting the argument that alterations in the gut fungal microbiome (the “mycobiome”), along with the presence of fungal elements within pancreatic tissue (specifically those of the genus Malassezia), are associated with pancreatic oncogenesis. Upon analyzing the human sequencing data presented in the original manuscript, we found few fungal reads in pancreatic tissue samples and did not identify differences in pancreatic or gut mycobiome composition between healthy and pancreatic ductal adenocarcinoma (PDAC) patients. Our re-analysis of these data does not support an association between an intrinsic pancreatic mycobiome and the development of human PDAC, and illustrates the challenges in analyzing microbiome sequencing data from low biomass samples.
Conflict of interest statement
Competing interests
The authors declare no competing interests.
Figures




Comment in
-
Reply to: Revisiting the intrinsic mycobiome in pancreatic cancer.Nature. 2023 Aug;620(7972):E7-E9. doi: 10.1038/s41586-023-06293-0. Nature. 2023. PMID: 37532815 No abstract available.
Comment on
-
The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL.Nature. 2019 Oct;574(7777):264-267. doi: 10.1038/s41586-019-1608-2. Epub 2019 Oct 2. Nature. 2019. PMID: 31578522 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical